A continence promotion intervention involving a pelvic floor muscle rehabilitation exercise program to reduce lower urinary tract, lower bowel symptoms and erectile dysfunction in men receiving radiation therapy with or without androgen deprivation therapy (ADT): A Pilot Study
Phase 2
- Conditions
- Prostate Cancer TreatmentLower Urinary Tract sequelae to radiation therapy with or without androgen deprivation therapyLower Bowel Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyErectile Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyCancer - ProstatePhysical Medicine / Rehabilitation - PhysiotherapyRenal and Urogenital - Other renal and urogenital disorders
- Registration Number
- ACTRN12612000527864
- Lead Sponsor
- niversity of Newcastle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Early stage prostate cancer
Exclusion Criteria
Not fluent in English
Neurological conditions
Other bladder conditions
Secondary malignancies
Profoundly Deaf
Legally blind
Abdominal surgery in past 2 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pelvic floor muscle rehabilitation in mitigating radiation-induced lower urinary tract symptoms in prostate cancer patients?
How does the continence promotion intervention in ACTRN12612000527864 compare to standard-of-care approaches for managing lower bowel dysfunction post-radiation therapy in prostate cancer?
Are there specific biomarkers associated with improved erectile function outcomes following pelvic floor muscle exercise programs in men undergoing androgen deprivation therapy for prostate cancer?
What adverse events are commonly reported in pelvic floor muscle rehabilitation programs for prostate cancer patients receiving radiation therapy with or without ADT, and how are they managed?
What combination therapies or alternative interventions have shown efficacy in addressing lower urinary tract and bowel symptoms alongside erectile dysfunction in prostate cancer treatment?